Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens (2Gether)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02291224
Recruitment Status : Completed
First Posted : November 14, 2014
Last Update Posted : November 27, 2018
Sponsor:
Collaborators:
Emory University
Grady Health System
Information provided by (Responsible Party):
Centers for Disease Control and Prevention

Brief Summary:

This trial will evaluate a multi-component, clinic-based intervention aimed at increasing dual protection strategy selection and adherence among young African American females at an urban family planning clinic. Dual protection is the use of contraceptive strategies to prevent both unintended pregnancy (UIP) and sexually transmitted infections (STIs). This is an unblinded randomized controlled trial; participants will either get the interactive multimedia platform focused on DP strategies with intervention arm counseling or the standard of care arm counseling.

The study will recruit 710 African American females aged 14-19 who are attending the Grady Health System (GHS) Teen Services Clinic (TSC) in Atlanta, Georgia, for reproductive health care.

The trial will recruit and enroll 710 young women presenting to the clinic for clinical care who have the following characteristics:

  • self-identify as African American,
  • 14-19 years of age,
  • have had vaginal sex with a male partner in the past 6 months,
  • HIV-negative by self-report,
  • not pregnant,verified by urine pregnancy test,
  • no desire to be pregnant in next 12 months,
  • plan to stay in the Atlanta area for the next year,
  • are willing to provide contact information, and
  • were not previously enrolled in the pilot study of this intervention.

Those enrolled will be in the study for 12 months. Young women who are eligible and give written consent or assent for study participation will be enrolled. Half will be randomized to the control arm, half to the intervention arm.

  1. Control arm (standard of care) includes individual clinical care and standard of care counseling consistent with protocols at the TSC, with study visits for data collection at enrollment, 6 months, and 12 months, during which any medical care or counseling that they would normally get will also be provided. Control arm participants will also get telephone calls from clinic staff to update their contact information and remind them of upcoming visits at 3 weeks and 5 months after the enrollment visit, and at 3 weeks and 5 months after the 6 month visit.
  2. Intervention arm, consisting of the following intervention components:

    1. Enrollment visit

      • A culturally-appropriate interactive multimedia platform focused on DP strategies and designed to prepare the individual for selection of a DP strategy.
      • Individual intervention arm counseling to select the DP strategy that is best suited for the participant (by a clinic health care provider).
      • Individual intervention arm counseling to build skills for correct and consistent use of the selected DP strategy (by a nurse educator (NE)).
    2. Booster counseling via phone at about 3 weeks and 5 months after the enrollment visit, and at about 3 weeks and 5 months after the 6 month visit (by an NE).
    3. 6 month visit

      • An abbreviated version of the interactive multimedia platform focused on dual protection strategies and strategy adherence.
      • Individual intervention arm counseling to reinforce skills for correct and consistent use of the DP strategy (by an NE).

At the final study visit at 12 months there is no difference between the counseling provided to the two groups; participants in both arms will receive the clinic standard of care.

Participants in both arms of the study will follow the same data collection procedures throughout the study:

  • At all three study visits, participants in both arms will receive urine pregnancy and STI tests and complete an audio computer assisted self-interview (ACASI) questionnaire.
  • At 3 and 9 months after enrollment, participants in both arms will receive a data collection call with administration of a telephone questionnaire.

Throughout the study, all participants will be encouraged to come in for evaluation if they have any concerns. Any data from pregnancy or STI testing at these interim clinic visits will be later collected via chart review. If participants seek reproductive health care at other facilities during the study period, records will be requested with participant permission, and data from pregnancy or STI testing at these outside clinic visits will be collected via review of records received.

We will examine the efficacy of the intervention arm relative to control arm across the following primary behavioral and biologic outcomes over the 12 months of follow-up:

  1. Self-reported dual protection strategy selection
  2. Self-reported dual protection strategy adherence
  3. Incidence of pregnancy or infection with chlamydia, gonorrhea or trichomonas (as confirmed by laboratory testing)

A small pilot study was be conducted prior to the initiation of enrollment in the main study.


Condition or disease Intervention/treatment Phase
Pregnancy Sexually Transmitted Diseases Behavioral: Interactive multimedia platform Behavioral: Intervention arm counseling Behavioral: Standard of care counseling Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 709 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens
Actual Study Start Date : March 2015
Actual Primary Completion Date : August 2018
Actual Study Completion Date : August 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Control
The control arm receives the clinic standard of care counseling. This includes individual clinical care and counseling consistent with protocols at the Grady Health System Teen Services Clinic, with study visits at enrollment, 6 months, and 12 months, during which any medical care or counseling included in the clinic standard of care will be provided. All control group members will see a provider on the day of enrollment. Control arm participants will get phone calls from clinic staff to update their contact information and remind them of upcoming appointments at 3 weeks and 5 months after both the enrollment visit and the 6 month visit. Participants may visit the clinic at any time and will be encouraged to come into the clinic for any concerns. If they have an interim visit during the study period, they will receive the clinic standard of care.
Behavioral: Standard of care counseling
Standard of care counseling is provided by health care providers and health educators at TSC. It incorporates extensive counseling on methods to prevent both unintended pregnancy and sexually transmitted infections, however the structure of the counseling and techniques used are dependent on the standard practice of each provider or educator. This counseling does not incorporate answers to reflection questions from the multi-media platform because control arm participants will not view this content.

Experimental: Intervention
  1. Enrollment

    • Interactive multimedia platform focused on DP strategies.
    • Intervention arm counseling by a health care provider to select DP strategy.
    • Intervention arm counseling and skill-building by a nurse educator (NE) on correct, consistent use of DP strategy.
  2. Booster counseling by an NE via phone at 3 weeks and 5 months after both the enrollment visit and the 6 month visit.
  3. 6 month visit

    • Abbreviated version of the interactive multimedia platform on DP strategies and adherence.
    • Intervention arm counseling by an NE to reinforce skills for correct, consistent use of DP strategy.
  4. Interim visits: Participants may visit the clinic at any time. If intervention group members visit the clinic for STI treatment or to switch birth control method, providers and/or NEs will follow structured counseling guides. If they have an interim visit for another reason, they will receive the clinic standard of care.
Behavioral: Interactive multimedia platform
An interactive platform that includes video vignettes of young women who are choosing dual protection strategies (based on a synthesis of focus group data from members of the TSC patient population), as well as true/false questions to build knowledge about dual protection and dispel common myths about contraceptive strategies. There will also be reflection questions that encourage participants to consider values and priorities in their own lives that may influence their dual protection strategy selection.
Other Name: MMDP

Behavioral: Intervention arm counseling
Counseling for the intervention group will follow carefully developed guides and incorporate the participants' answers to the reflection questions in the interactive multi-media component. This counseling has a set structure (set forth in separate counseling guides for health care providers and nurse educators), incorporates motivational interviewing techniques, includes multiple opportunities for role play, and is designed to be patient-centered.




Primary Outcome Measures :
  1. Participant selection of an effective dual protection (DP) strategy [ Time Frame: 6 months ]

    Whether or not a participant self-reports having selected an effective DP strategy. An effective DP strategy is defined as one of the following:

    • Abstinence from vaginal sex;
    • Effective non-barrier contraceptive method [including intrauterine device (IUD), Implant, Depo, or contraceptive pill, patch or ring] with consistent condom use;
    • Consistent condom use only

  2. Participant report of adherence to DP strategy [ Time Frame: 3 months ]

    By self-report from audio computer-assisted self-interviewing (ACASI) and telephone questionnaires; adherence is measured by three different outcomes:

    • Whether or not DP strategy was used at last sex
    • Whether or not DP strategy was used consistently during last 3 month time period
    • Estimated proportion of time adherent to DP strategy over last 3 months

  3. Time to first biologic event (pregnancy or diagnosis with STI) in participants [ Time Frame: Within 12 month period following enrollment ]
    Measured by date of positive lab test ("biologic event" refers to a positive pregnancy test or diagnosis with chlamydia, gonorrhea or trichomonas infection).

  4. Incidence of pregnancy and sexually transmitted infections (STIs) [ Time Frame: Within 12 month period following enrollment ]
    Includes the proportion of participants with a lab-confirmed diagnosis of pregnancy or lab-confirmed diagnosis with infection with chlamydia, gonorrhea or trichomonas within the 12 month follow-up period (testing either performed at study site clinic and documented at study visits and via chart review, or diagnosed by outside labs with documentation obtained via release of information procedures)

  5. Participant selection of an effective dual protection (DP) strategy [ Time Frame: 12 months ]

    Whether or not a participant self-reports having selected an effective DP strategy. An effective DP strategy is defined as one of the following:

    • Abstinence from vaginal sex;
    • Effective non-barrier contraceptive method [including intrauterine device (IUD), Implant, Depo, or contraceptive pill, patch or ring] with consistent condom use;
    • Consistent condom use only

  6. Participant report of adherence to DP strategy [ Time Frame: 6 months ]

    By self-report from audio computer-assisted self-interviewing (ACASI) and telephone questionnaires; adherence is measured by three different outcomes:

    • Whether or not DP strategy was used at last sex
    • Whether or not DP strategy was used consistently during last 3 month time period
    • Estimated proportion of time adherent to DP strategy over last 3 months

  7. Participant report of adherence to DP strategy [ Time Frame: 9 months ]

    By self-report from audio computer-assisted self-interviewing (ACASI) and telephone questionnaires; adherence is measured by three different outcomes:

    • Whether or not DP strategy was used at last sex
    • Whether or not DP strategy was used consistently during last 3 month time period
    • Estimated proportion of time adherent to DP strategy over last 3 months

  8. Participant report of adherence to DP strategy [ Time Frame: 12 months ]

    By self-report from audio computer-assisted self-interviewing (ACASI) and telephone questionnaires; adherence is measured by three different outcomes:

    • Whether or not DP strategy was used at last sex
    • Whether or not DP strategy was used consistently during last 3 month time period
    • Estimated proportion of time adherent to DP strategy over last 3 months

  9. Participant selection of an effective dual protection (DP) strategy [ Time Frame: At enrollment visit ]

    Whether or not a participant self-reports having selected an effective DP strategy. An effective DP strategy is defined as one of the following:

    • Abstinence from vaginal sex;
    • Effective non-barrier contraceptive method [including intrauterine device (IUD), Implant, Depo, or contraceptive pill, patch or ring] with consistent condom use;
    • Consistent condom use only


Secondary Outcome Measures :
  1. Participant level of reproductive health knowledge (percentage correct of knowledge questions) [ Time Frame: 6 months ]
    Knowledge about contraceptives and STIs, as measured by correct answers to knowledge questions on ACASI questionnaires.

  2. Participant intention to use DP strategy [ Time Frame: 6 months ]
    Whether or not participant self-reports intention to use an effective DP strategy in the future, as measured by responses on ACASI questionnaires.

  3. Participant reproductive health self-efficacy [ Time Frame: 6 months ]
    Whether or not participant reported high self-efficacy for condom use, contraceptive use, and communication with partner on reproductive health topics, as measured by responses on ACASI questionnaires.

  4. Participant report of STI testing [ Time Frame: 6 months ]
    Frequency of self-reported STI testing by participant and partner(s) and result-sharing with partner(s), as measured by responses to ACASI questionnaires.

  5. Participant report of partner communication [ Time Frame: 6 months ]
    Self-reported frequency of communication with partner on reproductive health topics, as measured by responses on ACASI questionnaires.

  6. Participant level of reproductive health knowledge (percentage correct of knowledge questions) [ Time Frame: 12 months ]
    Knowledge about contraceptives and STIs, as measured by correct answers to knowledge questions on ACASI questionnaires.

  7. Participant intention to use DP strategy [ Time Frame: 12 months ]
    Whether or not participant self-reports intention to use an effective DP strategy in the future, as measured by responses on ACASI questionnaires.

  8. Participant report of STI testing [ Time Frame: 12 months ]
    Frequency of self-reported STI testing by participant and partner(s) and result-sharing with partner(s), as measured by responses to ACASI questionnaires.

  9. Participant reproductive health self-efficacy [ Time Frame: 12 months ]
    Whether or not participant reported high self-efficacy for condom use, contraceptive use, and communication with partner on reproductive health topics, as measured by responses on ACASI questionnaires.

  10. Participant report of partner communication [ Time Frame: 12 months ]
    Self-reported frequency of communication with partner on reproductive health topics, as measured by responses on ACASI questionnaires.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years to 19 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • female,
  • self-identify as African American,
  • 14-19 years of age,
  • present to clinic on date of potential enrollment for clinical care,
  • has had vaginal sex with a male partner at least once in the past 6 months,
  • HIV-negative by self-report,
  • not currently pregnant (verified by urine pregnancy test),
  • desire to avoid pregnancy for at least 12 months,
  • plan to be in the Atlanta area for the next 12 months,
  • competent to participate in consenting or assenting process per recruiter evaluation,
  • willing to provide contact information, and
  • not previously enrolled in the pilot study of this intervention.

Exclusion Criteria:

  • pregnant
  • HIV positive

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02291224


Locations
Layout table for location information
United States, Georgia
Grady Health System Teen Services Clinic
Atlanta, Georgia, United States, 30303
Sponsors and Collaborators
Centers for Disease Control and Prevention
Emory University
Grady Health System
Investigators
Layout table for investigator information
Principal Investigator: Melissa Kottke, MD MPH MBA Emory University; Grady Health System
Principal Investigator: Jessica Sales, PhD Emory University
Principal Investigator: Athena Kourtis, MD PhD MPH Centers for Disease Control and Prevention
Study Director: Peggy Goedken, MPH Emory University
Layout table for additonal information
Responsible Party: Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier: NCT02291224    
Other Study ID Numbers: CDC-NCCDPHP-6588
DP12-001 ( Other Grant/Funding Number: CDC )
First Posted: November 14, 2014    Key Record Dates
Last Update Posted: November 27, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Keywords provided by Centers for Disease Control and Prevention:
dual protection
pregnancy
reproductive health
sexually transmitted diseases
condoms
contraception
adolescent health services
Additional relevant MeSH terms:
Layout table for MeSH terms
Sexually Transmitted Diseases
Infection
Virus Diseases